rs17433672

Variant names:

• chr3-152268473-C-T
• rs17433672
• ENST00000355460.6:c.-1409C>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_Strong BP6_Very_Strong BA1

The ENST00000355460.6(MBNL1):​c.-1409C>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0619 in 310,936 control chromosomes in the GnomAD database, including 841 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

• Frequency:
  • Genomes: 𝑓 0.059 (385 hom., cov: 32)
  • Exomes 𝑓: 0.065 (456 hom.)
• Consequence: MBNL1 ENST00000355460.6 5_prime_UTR_premature_start_codon_gain
• Clinical Significance: Benign criteria provided, multiple submitters, no conflicts B:2
• Conservation: PhyloP100: -2.41
• Publications: 1 publications found

Genes affected

MBNL1 (HGNC:6923): (muscleblind like splicing regulator 1) This gene encodes a member of the muscleblind protein family which was initially described in Drosophila melanogaster. The encoded protein is a C3H-type zinc finger protein that modulates alternative splicing of pre-mRNAs. Muscleblind proteins bind specifically to expanded dsCUG RNA but not to normal size CUG repeats and may thereby play a role in the pathophysiology of myotonic dystrophy. Mice lacking this gene exhibited muscle abnormalities and cataracts. Several alternatively spliced transcript variants have been described but the full-length natures of only some have been determined. The different isoforms are thought to have different binding specificities and/or splicing activities. [provided by RefSeq, Sep 2015]

MBNL1-AS1 (HGNC:44584): (MBNL1 antisense RNA 1)

ACMG classification

Our verdict: Benign. The variant received -20 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.73).
• BP6: Variant 3-152268473-C-T is Benign according to our data. Variant chr3-152268473-C-T is described in ClinVar as Benign. ClinVar VariationId is 218788.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
• BA1: GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.084 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000355460.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	MBNL1	NM_001376819.1		c.-790+24033C>T		intron	N/A	NP_001363748.1
	MBNL1	NM_001387781.1		c.-790+24033C>T		intron	N/A	NP_001374710.1
	MBNL1	NM_001387785.1		c.-790+24033C>T		intron	N/A	NP_001374714.1	A0A0A0MQX8

Ensembl Transcripts

Sel.	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	MBNL1	ENST00000355460.6	TSL:1	c.-1409C>T		5_prime_UTR_premature_start_codon_gain	Exon 1 of 9	ENSP00000347637.2	Q9NR56-2
	MBNL1	ENST00000355460.6	TSL:1	c.-1409C>T		5_prime_UTR	Exon 1 of 9	ENSP00000347637.2	Q9NR56-2
	MBNL1	ENST00000282488.11	TSL:5	c.-1409C>T		5_prime_UTR_premature_start_codon_gain	Exon 1 of 11	ENSP00000282488.8	A0A0A0MQX8

Frequencies

GnomAD3 genomes AF: 0.0587 AC: 8931 AN: 152194 Hom.: 385 Cov.: 32

Gnomad AFR AF: 0.0151

Gnomad AMI AF: 0.0549

Gnomad AMR AF: 0.0496

Gnomad ASJ AF: 0.0334

Gnomad EAS AF: 0.000385

Gnomad SAS AF: 0.0219

Gnomad FIN AF: 0.124

Gnomad MID AF: 0.0222

Gnomad NFE AF: 0.0858

Gnomad OTH AF: 0.0559

GnomAD4 exome AF: 0.0650 AC: 10310 AN: 158624 Hom.: 456 Cov.: 0 AF XY: 0.0586 AC XY: 5120 AN XY: 87374

African (AFR) AF: 0.00923 AC: 14 AN: 1516

American (AMR) AF: 0.0463 AC: 253 AN: 5462

Ashkenazi Jewish (ASJ) AF: 0.0302 AC: 97 AN: 3216

East Asian (EAS) AF: 0.00 AC: 0 AN: 3720

South Asian (SAS) AF: 0.0258 AC: 928 AN: 35986

European-Finnish (FIN) AF: 0.125 AC: 1022 AN: 8166

Middle Eastern (MID) AF: 0.0171 AC: 36 AN: 2108

European-Non Finnish (NFE) AF: 0.0820 AC: 7436 AN: 90678

Other (OTH) AF: 0.0674 AC: 524 AN: 7772

GnomAD4 genome AF: 0.0587 AC: 8934 AN: 152312 Hom.: 385 Cov.: 32 AF XY: 0.0591 AC XY: 4400 AN XY: 74484

African (AFR) AF: 0.0150 AC: 624 AN: 41578

American (AMR) AF: 0.0495 AC: 758 AN: 15306

Ashkenazi Jewish (ASJ) AF: 0.0334 AC: 116 AN: 3470

East Asian (EAS) AF: 0.000386 AC: 2 AN: 5184

South Asian (SAS) AF: 0.0221 AC: 107 AN: 4832

European-Finnish (FIN) AF: 0.124 AC: 1313 AN: 10610

Middle Eastern (MID) AF: 0.0238 AC: 7 AN: 294

European-Non Finnish (NFE) AF: 0.0859 AC: 5840 AN: 68012

Other (OTH) AF: 0.0553 AC: 117 AN: 2116

Alfa AF: 0.0659 Hom.: 599

Bravo AF: 0.0504

Asia WGS AF: 0.0130 AC: 45 AN: 3478

ClinVar

ClinVar submissions

Significance: Benign

Revision: criteria provided, multiple submitters, no conflicts

Pathogenic	VUS	Benign	Condition
-	-	1	not provided (1)
-	-	1	not specified (1)

Computational scores

Source: dbNSFP v4.9

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.73
CADD	Benign	0.68
DANN	Benign	0.86
PhyloP100		-2.4
PromoterAI		-0.012	Neutral
Mutation Taster		=300/0	polymorphism (auto)

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Other links and lift over

dbSNP: rs17433672;

hg19: chr3-151986262;